China National Accord Medicines (SZSE:000028) Interest Expense : ¥-244 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China National Accord Medicines's interest expense for the three months ended in Mar. 2024 was ¥ -55 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-244 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China National Accord Medicines's Operating Income for the three months ended in Mar. 2024 was ¥ 527 Mil. China National Accord Medicines's Interest Expense for the three months ended in Mar. 2024 was ¥ -55 Mil. China National Accord Medicines's Interest Coverage for the quarter that ended in Mar. 2024 was 9.62. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China National Accord Medicines Interest Expense Historical Data

The historical data trend for China National Accord Medicines's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Interest Expense Chart

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-271.72

-258.19

-288.04

-261.91

-248.38

China National Accord Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-58.98	-49.27	-75.27	-64.87	-54.75

China National Accord Medicines Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-244 Mil.

China National Accord Medicines (SZSE:000028) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China National Accord Medicines's Interest Expense for the three months ended in Mar. 2024 was ¥-55 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥527 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥1,642 Mil.

China National Accord Medicines's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	526.506	/	-54.747
	=	9.62

The higher the ratio, the stronger the company's financial strength is.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines